ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors
February 11, 2021 07:00 ET
|
ContraFect Corporation
YONKERS, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs)...